AVELUMAB
Manner of administration:Injection
Restriction (Streamlined authority code: 16085)
Indication: Stage IV (metastatic) Merkel Cell Carcinoma
Treatment phase: Continuing treatment
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 1200 mg | # of repeats: 11 | DPMA: $7,828.17 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| Bavencio
(avelumab 200 mg/10 mL injection, 10 mL vial)
|
||||
Manner of administration:Injection
Restriction (Streamlined authority code: 16053)
Indication: Stage IV (metastatic) Merkel Cell Carcinoma
Treatment phase: Initial treatment
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 1200 mg | # of repeats: 8 | DPMA: $7,982.14 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| Bavencio
(avelumab 200 mg/10 mL injection, 10 mL vial)
|
||||
Manner of administration:Injection
Restriction (Streamlined authority code: 16085)
Indication: Stage IV (metastatic) Merkel Cell Carcinoma
Treatment phase: Continuing treatment
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 1200 mg | # of repeats: 11 | DPMA: $7,982.14 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| Bavencio
(avelumab 200 mg/10 mL injection, 10 mL vial)
|
||||
Manner of administration:Injection
Restriction (Streamlined authority code: 16053)
Indication: Stage IV (metastatic) Merkel Cell Carcinoma
Treatment phase: Initial treatment
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 1200 mg | # of repeats: 8 | DPMA: $7,828.17 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| Bavencio
(avelumab 200 mg/10 mL injection, 10 mL vial)
|
||||
Manner of administration:Injection
Restriction (Streamlined authority code: 15485)
Indication: Locally advanced (Stage III) or metastatic (Stage IV) urothelial cancer
Treatment phase: Maintenance therapy - Initial treatment
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 800 mg | # of repeats: 7 | DPMA: $5,249.19 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| Bavencio
(avelumab 200 mg/10 mL injection, 10 mL vial)
|
||||
Manner of administration:Injection
Restriction (Streamlined authority code: 15485)
Indication: Locally advanced (Stage III) or metastatic (Stage IV) urothelial cancer
Treatment phase: Maintenance therapy - Initial treatment
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 800 mg | # of repeats: 7 | DPMA: $5,367.06 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| Bavencio
(avelumab 200 mg/10 mL injection, 10 mL vial)
|
||||
Manner of administration:Injection
Restriction (Streamlined authority code: 13290)
Indication: Locally advanced (Stage III) or metastatic (Stage IV) urothelial cancer
Treatment phase: Maintenance therapy - Continuing treatment
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 800 mg | # of repeats: 11 | DPMA: $5,249.19 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| Bavencio
(avelumab 200 mg/10 mL injection, 10 mL vial)
|
||||
Manner of administration:Injection
Restriction (Streamlined authority code: 13290)
Indication: Locally advanced (Stage III) or metastatic (Stage IV) urothelial cancer
Treatment phase: Maintenance therapy - Continuing treatment
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 800 mg | # of repeats: 11 | DPMA: $5,367.06 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| Bavencio
(avelumab 200 mg/10 mL injection, 10 mL vial)
|
||||
